Zurabio
  • About Us
  • Science
    • Torudokimab
    • ZB-168
    • ZB-106
  • Investors & Media
  • Contact
Select Page
JATT and Zura Bio to Create NYSE Listed Biotechnology Company

JATT and Zura Bio to Create NYSE Listed Biotechnology Company

by Ashle Whittle | Jun 17, 2022 | In The News, Press Releases

JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company Company advancing ZB-168, an anti-IL7Ra monoclonal antibody, originally developed by Pfizer Inc., in multiple phase 2 clinical...

Recent Posts

  • JATT and Zura Bio to Create NYSE Listed Biotechnology Company

Archive

  • June 2022

Address:
1489 W. Warm Springs Road, Suite 110
Henderson, NV 89014 USA

Phone: +1-702-757-6133
Email: [email protected]

About Us    |    Investors     |    Contact    |    Privacy Policy

© 2023 Zura Bio Ltd

All rights reserved